Dark Law · DL-026
SHE NOTIFIED THE PATIENTS ON MAY 2ND. THE UNIVERSITY BACKED APHELION PHARMA. SHE HAD SIGNED THE AGREEMENT HERSELF.
Dr. Miriam Tessier discovered liver fibrosis in twelve patients during a clinical trial for deferiprone. She notified participants in writing, prompting Aphelion Pharmaceuticals to threaten legal action for breaching a signed confidentiality agreement.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Law
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →Related Cases
Cases that share a governance or behavioural model with this one.
Sovereign Games
SG-038
HE SIGNED FOR EIGHTEEN MILLION. THE MINISTRY KEPT IT SECRET FOR FOURTE...
Shared: Stakeholder Engagement Model, Compliance and Ethics Program
Dark Law
DL-012
She Copied Files For Four Months. She Resigned In May 2021. They Read ...
Shared: Whistleblower Protection Policy, Stakeholder Engagement Model
Dark Sport
DS-007
She Found The Payment Records. The Rights Were Worth Billions. The Gif...
Shared: Risk Management Model, Stakeholder Engagement Model
The Model Room
MR-045
The Dark Pool Was Marketed As Protection From Predators. It Was Full O...
Shared: Whistleblower Protection Policy